Our services are centred around intellectual property that can be registered. We protect innovation, design, and branding across all sectors of industry, and at all stages in the supply chain.

For each IP right we offer services covering strategic advice, pre-registration searches, registrations and renewals, oppositions and dispute resolution. We handle work throughout the world, working with local colleagues in over 100 countries.


Our attorneys specialise in one or more sectors of industry, which enables them to provide quality advice with a commercial focus.

Our patent specialists have detailed understanding of the background technology, which ensures that your patent applications are prepared with the correct scope, reducing the likelihood of challenges from third parties and objections from the patent office.

They also advise whether other forms of protection would be more appropriate. Our brand specialists work with brand managers for leading brands and their advice is commercially focussed making sure that you get the best value from your budget.

18th Mar 2024

Trends in patents and innovation against cancer

“With an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths in 2020, cancer is a major global health threat”. This, quoted in the European Patent Office (EPO) “Patents and innovation against cancer” report of February 2024, highlights the scale of the challenge to researchers in the fight against this devastating disease.

20th Nov 2023

Gilead Sciences v NuCana: Lessons for parallel UK and EPO proceedings

In a UK Patents Court case decided earlier this year, Gilead Sciences v NuCana, Gilead sought revocation of the UK designations of two of NuCana’s European patents, EP 2955190B1 and EP 3904365B1, from the same family. These patents covered NuCana’s anti-cancer drug acelarin. NuCana counterclaimed that their patents were infringed by Gilead’s anti-viral products containing the compound sofosbuvir.

18th Oct 2023

World Menopause Day 2023: A brief overview of innovation within the menopause space

Today (18th October 2023) is World Menopause Day. According to the NHS, this day is needed to: “raise awareness, break the stigma and highlight the support available for improving health and wellbeing for those experiencing menopause.” Currently in the U.K. there are an estimated 13 million peri or post-menopausal women, with 77%[1] finding at least […]

2nd Oct 2023

Amgen v. Sanofi before the US Supreme Court and in Europe

In late May, the US Supreme Court published its opinion in Amgen v. Sanofi (Amgen, Inc. v. Sanofi, et al. 598 U.S. ____ (2023)). At issue was whether the specifications of Amgen’s US patents (US 8,829,165 and US 8,859,741) met the enablement requirement of the US statute, as outlined in 35 U.S.C. . § 112(a) — that is to say, whether the patents described the invention “in such full, clear, concise and exact terms as to enable any person skilled in the art…to make and use [the invention].”

23rd Aug 2023

The future of glucose monitoring

The non-invasive glucose monitoring device market is anticipated to progress substantially over the coming years. Industry expansion is likely to be propelled by the ever increasing prevalence of diabetes in modern society. According to the International Diabetes Federation (IDF), around 540 million adults (20-79 years) have diabetes, with almost half unaware that they have the condition. The IDF Diabetes Atlas projects the number of people living with diabetes will rise to 643 million by 2030 and to 783 million by 2045. Those who are diagnosed are required to frequently monitor their blood glucose levels to ensure they are at a safe level.

Saved Staff
Staff member

Remove all

Saved profiles
Call +44 (0)20 7242 0901
Call +44 (0)1223 360 350
Call +49 (0) 89 206054 267
Call +(00) 31 70 800 2162


    Register for notifications
    Enter your email address here to receive our monthly bulletin of IP news and developments.

    "*" indicates required fields

    I confirm that I have read Reddie & Grose's privacy notice and consent to my personal information being collected*
    Please read our privacy notice.